Short Interest in Aemetis, Inc. (NASDAQ:AMTX) Grows By 5.4%

Aemetis, Inc. (NASDAQ:AMTX) saw a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 5,710,000 shares, an increase of 5.4% from the May 31st total of 5,420,000 shares. Based on an average daily volume of 697,900 shares, the days-to-cover ratio is currently 8.2 days.

Aemetis Price Performance

Aemetis stock opened at $3.14 on Thursday. The firm’s fifty day moving average price is $3.50 and its 200 day moving average price is $3.92. The company has a market capitalization of $139.42 million, a price-to-earnings ratio of -2.68 and a beta of 1.32. Aemetis has a 12-month low of $2.75 and a 12-month high of $8.99.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, May 9th. The specialty chemicals company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.43) by ($0.15). The firm had revenue of $72.63 million during the quarter, compared to analyst estimates of $78.74 million. Analysts forecast that Aemetis will post -1.59 earnings per share for the current fiscal year.

Insider Buying and Selling at Aemetis

In other Aemetis news, Director John R. Block sold 51,580 shares of the business’s stock in a transaction dated Thursday, May 23rd. The stock was sold at an average price of $3.49, for a total transaction of $180,014.20. Following the completion of the sale, the director now owns 14,001 shares of the company’s stock, valued at $48,863.49. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 16.44% of the stock is owned by company insiders.

Institutional Trading of Aemetis

A number of hedge funds have recently made changes to their positions in AMTX. SG Americas Securities LLC bought a new position in Aemetis during the 1st quarter valued at $60,000. State Board of Administration of Florida Retirement System bought a new position in shares of Aemetis during the first quarter worth about $84,000. Citigroup Inc. lifted its position in shares of Aemetis by 10,391.3% during the third quarter. Citigroup Inc. now owns 75,013 shares of the specialty chemicals company’s stock worth $311,000 after purchasing an additional 74,298 shares during the last quarter. Finally, Stifel Financial Corp grew its stake in Aemetis by 58.0% in the third quarter. Stifel Financial Corp now owns 691,445 shares of the specialty chemicals company’s stock worth $2,870,000 after purchasing an additional 253,745 shares in the last quarter. Institutional investors and hedge funds own 27.02% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Truist Financial reissued a “hold” rating and issued a $4.00 target price (up previously from $3.50) on shares of Aemetis in a research note on Monday, May 13th. StockNews.com upgraded Aemetis to a “sell” rating in a research note on Monday, June 3rd. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research report on Friday, May 10th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Aemetis presently has a consensus rating of “Hold” and an average target price of $12.25.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.